In this episode: 

• Instead of efficacy, look at the secondary endpoints as vaccine data is being released
• Whilst the evidence for giving the AstraZeneca Oxford vaccine in patients over 65 yrs is small it is still a reasonable option
• TGA is maintaining a very watchful eye on all new vaccines 
• It is possible Australia will have 5 different vaccines available by the end of 2021 

Host: Dr David Lim | Total time: 27 mins

Guest: Dr Gary Grohmann, Virologist; Vaccine Manufacturing Expert; Former Director of Immunobiology and WHO ERL at the TGA, Office of Laboratories and Scientific Services

 

Register for our upcoming FREE WEBCAST

Tuesday 2 February 2020 | 7:00pm-9:00pm AEDT

Click here to register now!

See omnystudio.com/listener for privacy information.